Effect of BPA on Anchor Antibiotic Continuity in the ED: Randomized Controlled Trial
1 other identifier
interventional
420
1 country
1
Brief Summary
The objective is to compare the timeliness of anchor antibiotic administration in the emergency department (ED) after initial dosing with and without a Best Practice Alert in Epic (BPA) implemented to remind physicians to re-order the antibiotic. We hypothesize that post-BPA implementation, physicians will have a higher rate of ordering subsequent doses of antibiotics on-time and with the correct dosages compared to pre-BPA implementation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 20, 2020
CompletedFirst Submitted
Initial submission to the registry
October 27, 2020
CompletedFirst Posted
Study publicly available on registry
November 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2022
CompletedAugust 21, 2023
August 1, 2023
2.2 years
October 27, 2020
August 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Delay Time to Next Antibiotic Dose
The length of delay between time of expected antibiotic re-administration and the actual time of antibiotic re-administration
Between 0 and 24 hours after expected antibiotic re-administration
Secondary Outcomes (3)
Hospital Length-of-stay
Through study completion, up to 1 year
Admission to Intensive Care Unit (ICU)
Through study completion, up to 1 year
In-hospital mortality
Through study completion, up to 1 year
Study Arms (2)
Active Best Practice Alert
EXPERIMENTALCare providers taking care of these patients will receive a Best Practice Alert (BPA) in the electronic medical record (EMR) one hour before an antibiotic expires with no subsequent doses ordered. The BPA will prompt the care provider to re-order the antibiotic and give information on recommended dosage and frequency based on indication and patient characteristics.
Inactive Best Practice Alert
NO INTERVENTIONThe Best Practice Alert described in the Experimental Arm will not be active for patients in this arm. Care providers will proceed with usual care.
Interventions
This is a customized Best Practice Alert created at Mass General Brigham in the institutional Epic electronic medical record system.
Eligibility Criteria
You may qualify if:
- All adult patients (\>= 18 years old) who are seen in a Mass General Brigham Emergency Department who had a specific anchor antibiotic administered
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Related Publications (1)
Lee AH, McEvoy DS, Stump T, Stevens R, Deng H, Rubins D, Filbin M, Hayes BD, Rhee C, Dutta S. Implementation of an Electronic Alert to Improve Timeliness of Second Dose Antibiotics for Patients With Suspected Serious Infections in the Emergency Department: A Quasi-Randomized Controlled Trial. Ann Emerg Med. 2023 Apr;81(4):485-491. doi: 10.1016/j.annemergmed.2022.10.022. Epub 2023 Jan 18.
PMID: 36669909DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sayon Dutta, MD
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients will be masked to which group they are assigned. Care Providers will not be masked as they will be shown a Best Practice Alert (BPA) only for patients in the treatment arm. The investigators will not be masked.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
October 27, 2020
First Posted
November 9, 2020
Study Start
October 20, 2020
Primary Completion
December 20, 2022
Study Completion
December 20, 2022
Last Updated
August 21, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share
Given HIPAA concerns and lack of scientific need, we do not plan on sharing individual participant data (IPD).